Skip to content

Development of AI-Based Eye Movement Biomarkers for Early Diagnosis and Differential Models of Myasthenia Gravis

Development of AI-Based Eye Movement Biomarkers for Early Diagnosis and Differential Models of Myasthenia Gravis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011756
Enrollment
270
Registered
2026-03-20
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral, Others : This study is a non-invasive, behavioral-based clinical study that does not include therapeutic interventions such as medications, medical device treatments, procedures, or surger

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Inclusion Criteria for Patients with Myasthenia Gravis (MG) a. Patients diagnosed with myasthenia gravis who meet at least one of the following criteria: i. A significant decremental response on repetitive nerve stimulation testing ii. Positive acetylcholine receptor (AChR) antibody test iii. Positive muscle-specific kinase (MuSK) antibody test iv. Positive response to the neostigmine test v. Clinically significant findings on clinical examination and/or neuroimaging studies b. Individuals who have received an explanation of the purpose and methods of the study and have provided informed consent to participate in the study and examinations c. Adults aged 19 years or older and under 70 years of age (2) Inclusion Criteria for Patients with Cranial Nerve Palsy (CNP) a. Patients diagnosed with cranial nerve palsy who meet at least one of the following criteria: i. Unilateral involvement of the third, fourth, or sixth cranial nerve with definite limitation of extraocular movements ii. Clinically significant findings on clinical examination and/or neuroimaging studies b. Individuals who have received an explanation of the purpose and methods of the study and have provided informed consent to participate in the study and examinations c. Adults aged 19 years or older and under 70 years of age (3) Inclusion Criteria for the Control Group a. Adults aged 19 years or older and under 70 years of age with no neurological abnormalities b. Individuals who have received an explanation of the purpose and procedures of the study and have voluntarily provided written informed consent to participate c. Individuals who are able to cooperate with the administration of video-oculography (VOG) examinations

Exclusion criteria

Exclusion criteria: (1) Exclusion Criteria for Patients with Myasthenia Gravis (MG) a. Individuals under 19 years of age b. Individuals who do not provide informed consent to participate in the study c. Individuals who are unable to cooperate with the study examinations d. Individuals deemed inappropriate for study participation at the discretion of the investigator (2) Exclusion Criteria for Patients with Cranial Nerve Palsy (CNP) a. Individuals under 19 years of age b. Individuals who do not provide informed consent to participate in the study c. Individuals who are unable to cooperate with the study examinations d. Individuals deemed inappropriate for study participation at the discretion of the investigator (3) Exclusion Criteria for the Control Group a. Individuals under 19 years of age or over 70 years of age b. Individuals who do not provide informed consent to participate in the study c. Individuals who are unable to cooperate with the study examinations d. Individuals deemed inappropriate for study participation at the discretion of the investigator

Design outcomes

Primary

MeasureTime frame
Video-Oculography

Secondary

MeasureTime frame
Serum Ab level;Repetitive Nerve Stimulation Test;Tensilon Test;Ice Cube Test;Brain MRI;MG-ADL Score

Countries

Korea, Republic of

Contacts

Public ContactSunyoung Oh

Jeonbuk National University Hospital

ohsun@jbnu.ac.kr+82-63-250-1590

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 3, 2026